Keywords: kalypsys, complete, ph, ia, study, kd3010, drug

Kalypsys to complete Ph Ia study of KD3010

Article | 02 October 2006

Print This

US drug discovery and development company Kalypsys has initiated and expects to complete a Phase Ia clinical trial of KD3010, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in